FcRn Binding Affinity Prediction

The molecular switch governing FcRn binding is the protonation state of conserved histidine residues (H310, H435, H436) on the IgG Fc. At acidic pH (6.0), these residues become positively charged, enabling salt bridge formation with acidic residues (E117, E132) on the FcRn α-chain. At neutral pH (7.4), deprotonation disrupts these interactions, triggering release. Prediction models must accurately calculate pKa shifts in the local protein microenvironment.

• Key residues: H310, H435, H436 (IgG); E117, E132 (FcRn)
• pH transition: Binding at pH 6.0, release at pH 7.4
• Computational challenge: Accurate pKa prediction in buried protein interfaces

Beyond individual residue protonation, the overall electrostatic surface potential of the Fc CH2-CH3 domain must complement the FcRn α3-β2m interface. Poisson-Boltzmann calculations quantify the desolvation penalty and favorable Coulombic interactions. Engineered variants like the YTE mutant (M252Y/S254T/T256E) enhance electrostatic complementarity, shifting the binding isotherm.

• Method: Poisson-Boltzmann or Generalized Born models
• Key metric: Electrostatic binding free energy (ΔG_elec)
• Engineering target: Enhancing positive patch density near H310 pocket

The FcRn binding site lies at the CH2-CH3 domain interface, a region with intrinsic conformational flexibility. Molecular dynamics simulations reveal that the Fc domain samples open and closed states that modulate FcRn accessibility. Prediction pipelines must account for this conformational entropy penalty upon binding. Enhanced sampling techniques like metadynamics or replica exchange can map the free energy landscape of the apo state.

• Target region: CH2-CH3 interdomain angle
• Key technique: Accelerated MD or metadynamics
• Entropic cost: Restricting domain motion upon FcRn engagement

The conserved N297-linked glycan in the CH2 domain allosterically modulates FcRn binding. Truncated glycoforms (e.g., G0, Man5) alter the conformational dynamics of the Fc, indirectly affecting the FcRn interface. Machine learning models trained on glycan-specific binding data can predict how glycoengineering strategies impact neonatal receptor affinity.

• Key glycan: N297-linked biantennary complex type
• Allosteric mechanism: Glycan-CH2 packing modulates FcRn interface geometry
• Engineering approach: Afucosylation or galactosylation tuning

Alchemical free energy calculations provide the most rigorous physics-based prediction of mutational effects on FcRn binding affinity. FEP computes the relative binding free energy (ΔΔG) by gradually transforming one residue into another through a thermodynamic cycle. This method accurately ranks single-point mutations for half-life extension engineering.

• Method: Alchemical FEP with REST2 sampling
• Output: ΔΔG_bind with < 1 kcal/mol accuracy
• Application: Virtual scanning of Fc variant libraries

Physics-based simulations are computationally expensive. Graph neural networks (GNNs) and protein language models trained on FcRn binding data can serve as fast surrogates. These models learn structural and sequence determinants of affinity, enabling high-throughput virtual screening of thousands of Fc variants in seconds. Features include residue-level physicochemical properties, evolutionary conservation scores, and geometric descriptors of the binding interface.

• Architecture: Equivariant GNNs or ESM-2 embeddings
• Training data: SPR-measured FcRn affinity datasets
• Speed: >10,000 variants scored per minute

The machine learning-driven modeling of an antibody's absorption, distribution, metabolism, and excretion (ADME) profile. FcRn binding affinity is the single most critical input parameter for predicting the elimination phase and overall half-life. Models integrate physiologically-based pharmacokinetic (PBPK) frameworks with predicted FcRn binding constants at both acidic (pH 6.0) and neutral (pH 7.4) conditions to simulate recycling efficiency and clearance rates.

The rational engineering of an antibody's binding affinity to be conditional on the environmental pH. The core mechanism requires high-affinity binding to FcRn in the acidic endosome (pH ~6.0) to enable salvage from lysosomal degradation, coupled with rapid dissociation at physiological pH (7.4) to release the antibody back into circulation. Computational prediction focuses on identifying histidine residues and other protonatable groups in the Fc region that can be mutated to tune this pH switch.

The rational or computational modification of the antibody's constant region (CH2-CH3 domains) to modulate interactions with Fc receptors. For half-life extension, engineering targets the Fc-FcRn interface to enhance pH-dependent binding. Key variants include:

• M252Y/S254T/T256E (YTE): Increases FcRn affinity ~10-fold at pH 6.0 while maintaining pH-dependent release.
• M428L/N434S (LS): Extends half-life by enhancing FcRn binding in the endosome.
• T250Q/M428L: A combination variant with synergistic effects on recycling efficiency.

A multi-parameter computational evaluation of an antibody candidate's biophysical properties. When assessing FcRn-engineered variants, developability profiling must verify that half-life-extending mutations do not introduce liabilities:

• Thermal stability: Mutations in the CH2-CH3 interface can destabilize the Fc domain.
• Aggregation propensity: Engineered hydrophobic patches for FcRn binding may promote self-association.
• Chemical degradation: New sequence motifs may introduce deamidation or oxidation hotspots.
• Polyreactivity: Enhanced FcRn binding must not create non-specific interactions with other proteins.

Physics-based computational methods that simulate the atomic movements of the Fc-FcRn complex over microsecond timescales. These simulations reveal:

• Conformational dynamics of the FcRn binding interface at different pH conditions.
• Protonation state changes of critical histidine residues (H310, H435, H436) that act as the pH-sensing mechanism.
• Free energy calculations (MM-GBSA, alchemical free energy perturbation) to quantitatively predict binding affinity changes upon mutation.
• Water network analysis to identify solvent-mediated hydrogen bonds stabilizing the complex.

A computational framework that simultaneously optimizes an antibody sequence for multiple, often conflicting, properties. For FcRn engineering, the Pareto front balances:

• Maximizing FcRn affinity at pH 6.0 for enhanced recycling.
• Minimizing FcRn affinity at pH 7.4 to ensure efficient release.
• Preserving thermal stability and conformational integrity of the Fc domain.
• Maintaining Fc-gamma receptor binding if effector functions like ADCC are desired.
• Avoiding immunogenicity from neo-epitopes created by engineered mutations.